Andrew John Geall

This inventor holds 101 USPTO granted patents and 61 published patent applications, plus 6 CIPO patents and 34 EPO patents, primarily in RNA Delivery Systems (CPC class A61K2039-53). Top assignees: Glaxosmithkline Biologicals Sa, Avidity Biosciences, Inc., Vical Incorporated. Active years: 2008-2025.

USPTO Granted Patents = 101 (Patent Applications = 61)

% Patents Active = 89.1

CIPO Patents = 6 (Patent Applications = 19)

EPO Patents = 34 (Patent Applications = 76)

Average Co-Inventor Count = 2.7

ph-index = 24

Forward Citations = 1,422(Granted Patents)

Forward Citations (Not Self Cited) = 855(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Del Mar, CA (US) (2008 - 2011)
San Marcos, CA (US) (2012 - 2014)
San Diego, CA (US) (2023)
Littleton, MA (US) (2009 - 2024)
Cambridge, MA (US) (2012 - 2024)
Carlsbad, CA (US) (2019 - 2024)

Company Filing History:

53 out of 545

Glaxosmithkline Biologicals Sa

patents

25 out of 54

Avidity Biosciences, Inc.

Replicate Bioscience, Inc.

where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...

Areas of Expertise:

Nucleic Acid Compositions

RNA Purification

Immunogenic Compositions

Lipid Formulations

Muscle Atrophy Treatment

Myotonic Dystrophy

Immunization Methods

Pegylated Liposomes

Virus Infection Prevention

Multi-Exon Skipping

Immune Pathways

101 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12497615 - NUCLEIC ACID COMPOSITIONS AND METHODS OF MULTI-EXON SKIPPING (2025-12-16),

2. 12364769 - Nucleic acid-polypeptide compositions and uses thereof (2025-07-22),

3. 12351637 - Nucleic acid-polypeptide compositions and uses thereof (2025-07-08),

4. 12263224 - Compositions and methods of treating muscle atrophy and myotonic dystrophy (2025-04-01),

5. 12234290 - Nucleic acid-polypeptide compositions and uses thereof (2025-02-25),

6. 12186333 - Delivery of RNA to trigger multiple immune pathways (2025-01-07),

7. 12064483 - Nucleic acid-polypeptide compositions and methods of inducing exon skipping (2024-08-20),

8. 12018044 - RNA purification methods (2024-06-25),

9. 11913001 - Immunisation of large mammals with low doses of RNA (2024-02-27),

10. 11905514 - Immunisation of large mammals with low doses of RNA (2024-02-20),

11. 11896636 - Immunogenic combination compositions and uses thereof (2024-02-13),

12. 11891608 - Immunization of large mammals with low doses of RNA (2024-02-06),

13. 11883534 - Immunisation with lipid formulations with RNA encoding immunogens (2024-01-30),

14. 11872287 - Compositions and methods of treating muscle atrophy and myotonic dystrophy (2024-01-16),

15. 11865080 - Delivery of RNA to trigger multiple immune pathways (2024-01-09),

Title: The Innovative Mind of Andrew John Geall

Introduction: Andrew John Geall, a talented inventor based in Carlsbad, CA, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Andrew John Geall holds several patents in the areas of renewable energy, sustainable materials, and advanced electronics, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Andrew John Geall has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Andrew John Geall has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and excellence in all his projects. His collaborative spirit has led to the successful implementation of numerous groundbreaking ideas.

Conclusion: Andrew John Geall's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, has solidified his reputation as a visionary inventor in the field of technology. His contributions continue to inspire and shape the future of innovation worldwide.